Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05664841 · ClinicalTrials.gov registry record · Phase 2
The Impact of a Virtual Magic Trick Training Program
A Phase 2 study of Autism and Pervasive Developmental Disorder, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05664841: Recruiting Phase 2 study of Autism and Pervasive Developmental Disorder, sponsored by University of Alabama at Birmingham.
NCT05664841 is a Phase 2 study of Autism and Pervasive Developmental Disorder that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 60 participants, below the 183-participant average among 104 other Autism trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05664841, a Phase 2 study of Autism and Pervasive Developmental Disorder, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed project will attempt to confirm the benefits of a structured magic trick training program (MTTP) experience in adolescents with autism. Benefits of participating in a 6-week virtual MTTP will be evaluated using validated assessments to measure social-emotional competencies.
Primary Outcome
The TASSK is a self-report 30-item questionnaire that measures knowledge of specific social skills. Scores range between 0 to 26 with higher score reflecting greater knowledge of adolescent social skills.
Conditions Studied
Interventions
- BEHAVIORAL magic trick training
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-03-27 |
| Est. Completion | 2028-02-01 |
| Phase | Phase 2 |
What NCT05664841 shows while recruiting
NCT05664841 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 183-participant average among 104 other Autism trials with a reported enrollment target (67% lower).
The record links to 2 conditions, with Autism appearing as the primary indexed condition, and to 1 intervention - of which magic trick training is the first listed.
NCT05664841 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT05664841 about?
NCT05664841 is a clinical study titled "The Impact of a Virtual Magic Trick Training Program". The proposed project will attempt to confirm the benefits of a structured magic trick training program (MTTP) experience in adolescents with autism. Benefits of participating in a 6-week virtual MTTP will be evaluated using validated assessments to measure social-emotional competencies.
What is the current status of trial NCT05664841?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2023-03-27. Estimated completion is 2028-02-01.
What conditions does trial NCT05664841 study?
This clinical trial studies the following conditions: Autism, Pervasive Developmental Disorder.
What interventions are being tested in trial NCT05664841?
The interventions under investigation include: magic trick training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05664841?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05664841 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05664841's enrollment target sits among peer trials
60 53rd of 104 higher than 51 of 104 other Autism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Optimizing Outcomes for Young Autistic Children
RECRUITING · Phase 2
-
Trial of Zolpidem for Sleep in Children With Autism
RECRUITING · Phase 2
-
A Study of Esomeprazole in Children With Autism
RECRUITING · Phase 2
-
Trial of Diphenhydramine for Sleep in Children With Autism
RECRUITING · Phase 2
-
Trial of Suvorexant for Sleep in Children With Autism
RECRUITING · Phase 2
-
Trial of Cannabidiol to Treat Severe Behavior Problems in Children With Autism
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI